2-tert-butylhydroquinone has been researched along with probucol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aburatani, H; Hamakubo, T; Ishii, M; Izumi, A; Kodama, T; Mataki, C; Niki, E; Noguchi, N; Takabe, W; Wada, Y | 1 |
Braga, AL; Colle, D; de Bem, AF; Engel, DF; Farina, M; Godoi, M; Hartwig, JM; Santos, DB | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and probucol
Article | Year |
---|---|
Gene expression induced by BO-653, probucol and BHQ in human endothelial cells.
Topics: Antioxidants; Arteriosclerosis; Benzofurans; Cells, Cultured; Cysteine Endopeptidases; Cytochrome P-450 CYP1A1; Endothelium, Vascular; Female; Gene Expression; Humans; Hydroquinones; Male; Multienzyme Complexes; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Probucol; Proteasome Endopeptidase Complex; RNA, Messenger | 2000 |
Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity.
Topics: Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cell Survival; Glutamate-Cysteine Ligase; Glutathione; Glutathione Peroxidase; Humans; Hydroquinones; Hypolipidemic Agents; Mitochondria; Nitro Compounds; Oxidative Stress; Probucol; Propionates; Protective Agents; RNA, Messenger; Time Factors; Up-Regulation | 2016 |